HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Defends Ephedra Ban Procedures In Nutraceutical Case Filing

This article was originally published in The Tan Sheet

Executive Summary

FDA followed required rulemaking procedures in issuing a final rule that banned ephedra dietary supplements, the agency argues in a response brief filed in its ongoing legal battle with Nutraceutical Corp

You may also be interested in...



Consumer Groups Uneasy, FDA Cautious Over Nanotech In Supplements

Nanotechnology applications in dietary supplements and food additives demand FDA's immediate attention and guidance, consumer advocates say. Agency officials and industry groups, however, tend to support a more measured approach and show fewer signs of concern about nano products

New Supplement Rule Was Not Previewed in Ephedra Proposal – Nutraceutical

FDA's 1997 proposed rule on ephedra did not foreshadow the agency applying a new adulteration standard to all dietary supplements; this renders the 2004 ban a violation of the Administrative Procedures Act, Nutraceutical Corp. argues in the latest filing in its suit against the agency

Nutraceutical/Supreme Court update

Solicitor General Paul D. Clement has asked the clerk of the Supreme Court to give his office an extension until March 7 to file the government's response to Nutraceutical Corp.'s petition for writ of certiorari, Nutraceutical attorney Jonathan Emord tells "The Tan Sheet" in a Feb. 1 e-mail. "This is significant. Of approximately 10,000 cert petitions filed within the Court, the Solicitor General's office responds to but a fraction of these," Emord writes. The Department of Justice "uses criteria for assessing cert worthiness and files responses only to those petitions that they think may be granted by the Court," he explains. Nutraceutical filed its petition for writ of certiorari Jan. 3 (1"The Tan Sheet" Jan. 8, 2007, p. 8). Separately, Nutraceutical filed a pleading Feb. 9 in the U.S. District Court for the District of Utah. The pleading rebuts FDA's Jan. 18 response to Nutraceutical's renewal of its case against the agency (2"The Tan Sheet" Jan. 29, 2007, p. 9)...

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS138253

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel